Immunohistochemical staining of ras oncogene product in neoplastic and non-neoplastic mesothelial tissues: immunoreactivity for N-ras and lack of immunohistochemical staining for Ha-ras and K-ras.
Immunohistochemical staining of 36 malignant mesotheliomas and 45 cases of non-neoplastic mesothelium including 20 specimens with signs of hyperplasia were investigated using murine monoclonal antibodies directed against p21 ras protein, Ha-ras protein, K-ras protein, and N-ras protein. All cases of non-neoplastic mesothelium and the majority of the malignant mesotheliomas (78 per cent) showed cytoplasmic and often submembranous immunoreactivity in more than 50 per cent of the cells with both the pan-ras and N-ras antibody. No immunoreactivity was observed for Ha- and K-ras. There was no statistically significant difference with respect to immunoreactivity between neoplastic and non-neoplastic mesothelium or between the various mesothelioma subtypes.
Ramael
M
M
Department of Pathology, University Hospital Antwerp, Belgium.
Deblier
I
I
Eerdekens
C
C
Lemmens
G
G
Jacobs
W
W
Van Marck
E
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor / Q000032:analysis*; D002462:Cell Membrane / Q000737:chemistry; D003593:Cytoplasm / Q000737:chemistry; D004848:Epithelium / Q000737:chemistry*; D005260:Female; D006801:Humans; D006965:Hyperplasia / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D008654:Mesothelioma / Q000737:chemistry*; D051379:Mice; D008875:Middle Aged; D016283:Proto-Oncogene Proteins p21(ras) / Q000032:analysis*
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)